RF
Insider
Richard D Francis
President and CEORichard D Francis (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $15.3M of TEVA (447,778 sh across 2 lots, as filed), executed Feb 15.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$31.3M
shares × price, as filed
Last traded
Jun 5
Filed Jun 8
Median ADV $196.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $33.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
TEVARecent filings
TEVASALE
Teva Pharmaceutical Industries Limited
View filing →
$211K6,153 sh × $34.35
Exec Jun 5
Filed Jun 8 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $634K
20,025 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $759K
23,393 sh × $32.46
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $14.3M
442,935 sh across 2 lots
Exec Mar 3
Filed Mar 5 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $15.3M
447,778 sh across 2 lots
Exec Feb 15
Filed Feb 18 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $375K
23,773 sh across 2 lots
Exec Mar 4 2025
Filed Mar 6 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $503K
31,342 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited View filing → $1.3M
75,506 sh × $16.95
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET